Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sedmak

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Transplantation|February 1, 1993
Analysis of inflammatory endothelial changes, including VCAM-1 expression, in murine cardiac graftsR P Pelletier, C J Morgan, D D Sedmak, et al.
American Journal of Clinical Pathology|November 14, 2002
Analysis of the molecular quality of human tissues: an experience from the Cooperative Human Tissue NetworkScott D Jewell, Mythily Srinivasan, Linda M McCart, et al.
Cytokine|August 30, 2002
The expression of the cytomegalovirus chemokine receptor homolog US28 sequesters biologically active CC chemokines and alters IL-8 productionJulie-Randoph Randolph-Habecker, Brian Rahill, Beverly Torok-Storb, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 24, 1998
Successful DNA transfer in cultured human mesangial cells using replication deficient recombinant adenovirusN S Nahman, K R Clark, T J Sferra, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 10, 1997
Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodellingC G Orosz, E H Huang, S D Bergese, et al.
Transplantation|February 1, 1990
Inability of cytomegalovirus infection of cultured endothelial cells to induce HLA class II antigen expressionD D Sedmak, W H Roberts, R E Stephens, et al.
The Journal of Experimental Medicine|March 28, 1998
Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathwayD M Miller, B M Rahill, J M Boss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1992
Alloantigenicity of human endothelial cells. 1. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cellsP W Adams, H S Lee, W J Waldman, et al.
Transplantation|October 9, 1999
Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomideW J Waldman, D A Knight, N S Lurain, et al.
Transplantation|September 27, 1995
Patterns of inflammatory vascular endothelial changes in murine liver graftsU Dahmen, S D Bergese, S Qian, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Transplantation|February 1, 1993
Analysis of inflammatory endothelial changes, including VCAM-1 expression, in murine cardiac graftsR P Pelletier, C J Morgan, D D Sedmak, et al.
American Journal of Clinical Pathology|November 14, 2002
Analysis of the molecular quality of human tissues: an experience from the Cooperative Human Tissue NetworkScott D Jewell, Mythily Srinivasan, Linda M McCart, et al.
Cytokine|August 30, 2002
The expression of the cytomegalovirus chemokine receptor homolog US28 sequesters biologically active CC chemokines and alters IL-8 productionJulie-Randoph Randolph-Habecker, Brian Rahill, Beverly Torok-Storb, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 24, 1998
Successful DNA transfer in cultured human mesangial cells using replication deficient recombinant adenovirusN S Nahman, K R Clark, T J Sferra, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 10, 1997
Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodellingC G Orosz, E H Huang, S D Bergese, et al.
Transplantation|February 1, 1990
Inability of cytomegalovirus infection of cultured endothelial cells to induce HLA class II antigen expressionD D Sedmak, W H Roberts, R E Stephens, et al.
The Journal of Experimental Medicine|March 28, 1998
Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathwayD M Miller, B M Rahill, J M Boss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1992
Alloantigenicity of human endothelial cells. 1. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cellsP W Adams, H S Lee, W J Waldman, et al.
Transplantation|October 9, 1999
Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomideW J Waldman, D A Knight, N S Lurain, et al.
Transplantation|September 27, 1995
Patterns of inflammatory vascular endothelial changes in murine liver graftsU Dahmen, S D Bergese, S Qian, et al.
Pageof 12